Development and Treatment of Tertiary Hyperparathyroidism in Patients with Pseudohypoparathyroidism Type 1B | Zendy

Nicola M. Neary | Zendy; Diala ElMaouche | Zendy; Rachel Hopkins | Zendy; Steven K. Libutti | Zendy; Arnold M. Moses | Zendy; Lee S. Weinstein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Development and Treatment of Tertiary Hyperparathyroidism in Patients with Pseudohypoparathyroidism Type 1B

Author(s) -

Nicola M. Neary,

Diala ElMaouche,

Rachel Hopkins,

Steven K. Libutti,

Arnold M. Moses,

Lee S. Weinstein

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2012-1655

Subject(s) - pseudohypoparathyroidism , tertiary hyperparathyroidism , medicine , hyperparathyroidism , pediatrics , endocrinology , parathyroid hormone , parathyroidectomy , calcium

Pseudohypoparathyroidism type 1B (PHP1B) patients have PTH resistance at the renal proximal tubule and develop hypocalcemia and secondary hyperparathyroidism. Hyperparathyroid bone disease also develops in some patients. PHP1B patients are at theoretical risk of developing tertiary hyperparathyroidism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research